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Fostering Europe’s Future Physician-Scientists: An Interview 
with European MD/PhD Association Chairman Dr. André dos 
Santos Rocha 
Paul M. Ryan,1,2 André dos Santos Rocha.2,3 
The Interview 
Dr. André dos Santos Rocha is a Resident Physician in Intensive Care 
Medicine & Anaesthesiology and a current MD-PhD student in the 
Department of Acute Medicine at the University of Geneva (Figure 1). In 
parallel, he is also the current Chairman of the European MD/PhD 
Association (EMPA), a role in which he coordinates a diverse group of 
highly-driven MD-PhD students. EMPA is a not-for-profit organisation 
which was founded with the central aims of bringing together MD-PhDs 
from across Europe, fostering a comfortable setting for networking, 
promoting European scientific collaborations and support for research, 
and mobilizing European MD-PhD students. One of the main mediums 
through which EMPA achieves a number of these lofty goals is their 
annual conference, which is typically held in conjunction with one of 
the national associations. I met with Dr. Dos Santos Rocha after the 
recent European and Swiss MD-PhD Conference in Geneva to discuss 
his experience in this role and what the future holds for EMPA. 
 
Paul MacDaragh Ryan (PMR): Good afternoon, André. Many thanks for 
agreeing to educate us on EMPA and your involvement in the 
organisation. To start, can you tell us a bit about your career to date, 
your research and what drew you into medicine initially? 
 
Dr. André dos Santos Rocha (ASDR): Hi Paul! Thank you for joining EMPA 
and especially for reaching out to me for this conversation. My career 
to date has been divided between a number of European countries. I 
attended medical school in Lisbon, completing the final two years of 
my undergraduate education in Paris and London, respectively. It is 
somewhat difficult for me to go back to the very first moments that 
drove me into medicine. I must have been 12 or 13 years old when, 
already fascinated by the natural sciences, my older cousin brought me 
to visit the Intensive Care Unit (ICU) “space shuttle” room at one of the 
biggest hospitals in Portugal. Of course, it was difficult not to be 
fascinated by this back at that age. Many years later, I was attracted 
by medicine for its humanistic aspects, the art of its practice and the 
endless innovation which keeps it in motion. 
 
After graduating from my undergraduate studies in 2013, I launched 
into residency in ICU/Anaesthesiology in Switzerland. Subsequently, in 
2017, I put my clinical training on hold to pursue an MD-PhD programme 
in Geneva. My research focuses on respiratory biophysics and 
pathophysiology during mechanical ventilation. Naturally, my choices 
and career in research were guided by my experience in the ICU. 
 
PMR: What is the one piece of advice which you would give to someone 
who is currently considering applying to an MD-PhD program? 
Figure 1. Dr. André dos Santos Rocha, University of Geneva MD-PhD Student 
& EU MD/PhD Association Chairman. Pictured here with a Geneva EMPA 
Conference attendee. 
 
 
 
 
ADSR: I would rather say that if someone is actively considering 
applying to such a research track, they very likely possess the core 
skills which fuel research: motivation and scientific curiosity. With this 
in mind, now is the right moment to dive into it without fear. It might 
seem long, laborious and disconnected from the usual clinician track, 
but you will probably become one of a kind amongst your peers. To 
hold an MD-PhD title and education is rarely undervalued. 
 
PMR: What have been the biggest challenges and rewards of the MD-
PhD route for you so far? 
ADSR: I guess the challenges and struggles are quite similar to all of us: 
to find enough financial and personal support, as well as to have 
guidance for both our experiments and careers. It is of course 
challenging to attain a salary which is equivalent to our 
peers/colleagues who are solely performing clinical duties. On a 
personal note, I would say that becoming a student again many years 
after leaving medical school was the biggest challenge. As a junior 
doctor, my sense of autonomy and fulfilment increased exponentially. 
You can imagine what it was like at first to go back to didactic lectures, 
amphitheatres and a laboratory bench as a full-time job. 
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Figure 2. Delegates of the 8th EU MD/PhD Association Conference. More than 70 delegates representing 15 nationalities attended the meeting at Campus 
Biotech, Geneva, Switzerland. 
 
 
 
 
However, I would not dare to complain since a range of otherwise 
unattainable rewards revealed themselves along the way – jobs, 
positions, prizes & grants, the EMPA presidency – but the greatest 
reward is the respect and recognition from my physician peers 
whenever I go to seminars and conferences to present my experimental 
data. 
 
PMR: In your opinion, what are the key features of an impactful or 
successful Physician-Scientist? 
ADSR: This question has no easy answers. Through EMPA, I have had 
the chance to meet and interact with many colleagues from different 
countries, programmes and backgrounds. Each career seems so unique 
and they all are meant to lead to a successful physician-scientist 
profile. From my perspective, two aspects deserve special attention 
whether one wants to successfully combine clinics and research: career 
planning and mentorship. While your PhD is still ongoing, dedicate 
some time to discuss with your mentors your next steps and future 
plans, apply to grant opportunities and manage research protected 
time with your institution. I believe that these key features will help 
pave the way to a fruitful career. 
 
PMR: What are your future career and scientific aspirations? 
ADSR: Regarding medical training, I will pursue my Anaesthesiology & 
ICU specialised training. Simultaneously, I am managing a non-
interventional clinical trial that aims to bridge and validate my 
preclinical data within clinical scenarios. I was lucky to be awarded 
Swiss National funding to support my research during residency and, 
therefore, I am planning to acquire clinical research skills alongside 
medical training. Regarding my long-term career aspirations, the plan 
is to take a path such that academia and research can accompany my 
clinical duties. 
 
PMR: Can you tell us about the history of EMPA and where it found its 
origins? 
ADSR: MD-PhD gatherings at the European level started in London in 
2012. Back then, EMPA did not exist but the informal association 
between students from European MD-PhD programmes started by 
bringing together annual international MD-PhD conferences throughout 
Europe. It was in 2015, during the 4th European MD-PhD Conference in 
Groningen, The Netherlands, that EMPA was born with an official 
registration in the Chamber of Commerce, its statutory terms, its 
Executive and Advisory Boards. The heritage from this “birth” is that 
our website servers, financial and legal headquarters are still in 
Groningen today. 
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PMR: When and how did you become involved in EMPA? 
ADSR: It was back to 2017, when I attended the 6th Swiss and European 
MD-PhD Conference in Basel. I got to know EMPA’s goals and projects 
during the General Assembly and I was recruited to join the movement, 
just as happened to you in Geneva lately. By the way, thank you for 
becoming the National Representative for EMPA in Ireland. 
 
PMR: You recently successfully orchestrated the 2019 European and 
Swiss MD-PhD Conference in the beautiful Campus Biotech setting of 
Geneva, Switzerland. Can you tell us a bit about this? 
ADSR: Having joined EMPA in Basel as I mentioned, it was now my turn 
to bring the European MD-PhD Conference to Swiss ground once again 
and to spread EMPA’s mission to new members from European 
Universities. In partnership with the Swiss MD-PhD Association, in 
which I am the international liaison, we co-organised the 8th annual 
EMPA conference at Campus Biotech, the Life Sciences’ Hub for the 
region of Lake Geneva (Figure 2). Dedicated to Biotechnology in Health, 
this year's conference gathered over 70 MD-PhD candidates and 
graduates, allowing young doctors to present their unique research 
work and to network with peers, while enjoying a rich scientific 
programme delivered by a range of experts in the field from across 
Europe and the United States. 
 
PMR: What were the major highlights and take-home messages of the 
conference for you? 
ADSR: The major highlight was the presence of more than 70 attendees, 
from 15 nationalities with a wide range of ages, backgrounds and 
interests. About twenty original scientific works were selected for oral 
presentation, in addition to a range of poster presentations, and the 
high quality of the research done by students during their PhD pursuits 
was remarkable. These pluralistic demographics is the proof that EMPA 
shall foster international collaborations, given the rich and highly 
diverse curricular framework throughout Europe. 
 
PMR: While Europe was certainly the home to many of the first true 
physician-scientists, the United States was the first country to develop 
the formal MD-PhD program more than 50 years ago.1 What is the 
current state of MD-PhD programs in Europe? 
ADSR: Thanks for raising this issue, which is so dear to me. Indeed, the 
Old Continent has certainly an older and richer scientific history, but 
for some reason we were far slower than our American peers in 
developing MD-PhD programmes. It was in the late 80’s and early 90’s 
that the first programmes appeared in the UK, France and Switzerland. 
Efforts have been growing (albeit slowly) ever since and other countries 
and universities have begun to design PhD programmes tailored for 
medical students and clinicians. Despite this, the current state in 
Europe could still be vastly improved, since many countries still lack 
these programmes entirely. In line with this, we have made it a priority 
of EMPA over the past few years to host national events and forums in 
different countries in order to promote tailored programmes for medical 
doctors wishing to follow PhD tracks. 
  
PMR: What do you hope to achieve during your term as Chairman and 
what is the long-term future of EMPA? 
ADSR: My biggest goal as chairman is to be a facilitator and promotor 
of international collaborations. In the past, the divergent design of MD-
PhD programmes in Europe created some divisions between countries.3 
To heal old wounds, we came up with a new definition and modified 
our statutes accordingly in 2019 to include in our ranks all health care 
professionals and students with an interest in biomedical research, in 
particular physicians, pharmacists and dentists. 
 
As a most sincere personal and associative goal, I hope to achieve 
consortiums and consensus between the different players inside and 
outside Europe. I am happy to announce that we have been signing 
memorandums of agreement with many universities and associations 
to provide better network and training opportunities for our members. 
To mention just one, we established the International Consortium of 
Clinician Scientist Trainees’ Organisation together with American, 
Canadian, Asian, French and Swiss physician-scientists associations.2 
 
PMR: How can interested students find more information about EMPA 
and get involved in the organisation? 
ADSR: We have several channels of communication through which we 
are eager to connect, such as Facebook,4 Twitter5 and LinkedIn,6 along 
with our website,7 where an events calendar and useful information are 
continuously updated. Finally, I would be happy to receive and reply to 
any inquiries directly via the EMPA email address, 
eumdphdassociation@gmail.com. 
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